Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.

por Mutirangura, A., Sriuranpong, V., Termrunggraunglert, W., Tresukosol, D., Lertsaguansinchai, P., Voravud, N., Niruthisard, S.
Publicado 1998

Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

por Mutirangura, A., Tanunyutthawongese, C., Pornthanakasem, W., Kerekhanjanarong, V., Sriuranpong, V., Yenrudi, S., Supiyaphun, P., Voravud, N.
Publicado 1997

Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

por Yoshino, T., Van Cutsem, E., Li, J., Shen, L., Kim, T.W., Sriuranpong, V., Xuereb, L., Aubel, P., Fougeray, R., Cattan, V., Amellal, N., Ohtsu, A., Mayer, R.J.
Publicado 2022

OP12 Durability and immunogenicity after two doses of ChAdOx1 nCov-19 among the type of cancer treatment in oncologic patients: A prospective, multicenter observational study

por Wanchaijiraboon, P., Teeyapun, N., Luangdilok, S., Wanlapakorn, N., Sainamthip, P., Pakvisal, N., Namkanisorn, T., Sriuranpong, V., Phaibulvatanapong, E., Veranitinun, R., Inthasuwan, P., Sartsuk, C., Phongwan, R., Angspatt, P., Wongchanapat, P., Poovorawan, Y., Tanasanvimon, S.
Publicado 2022